Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,812,468
in 11 filings, $79.8M under 10b5-1 plans

Net −$79,812,468. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-14 LYONS GARY A Director Option exercise · Stock option (right to buy) 10b5-1 +8,000 0
2026-04-14 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale 10b5-1 −9 $41.07 $370 125,152
2026-04-14 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale 10b5-1 −7,239 $41.93 $304K 117,913
2026-04-14 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −7,215 $41.93 $303K 112,491
2026-04-14 Heerma Peter CHIEF COMMERCIAL OFFICER Sale −7,215 $41.93 $303K 138,608
2026-04-14 REED ELIZABETH E Chief Legal Officer and GC Option exercise 10b5-1 +10,000 $19.08 $191K 129,211
2026-04-14 REED ELIZABETH E Chief Legal Officer and GC Option exercise 10b5-1 +20,000 $17.96 $359K 149,211
2026-04-14 REED ELIZABETH E Chief Legal Officer and GC Option exercise 10b5-1 +7,500 $15.46 $116K 156,711
2026-04-14 REED ELIZABETH E Chief Legal Officer and GC Sale 10b5-1 −37,500 $41.07 $1.5M 119,211
2026-04-14 REED ELIZABETH E Chief Legal Officer and GC Sale 10b5-1 −7,215 $41.93 $303K 111,996
2026-04-14 REED ELIZABETH E Chief Legal Officer and GC Option exercise · Employee stock option (right to buy) 10b5-1 −7,500 37,500
2026-04-14 REED ELIZABETH E Chief Legal Officer and GC Option exercise · Employee stock option (right to buy) 10b5-1 −10,000 0
2026-04-14 REED ELIZABETH E Chief Legal Officer and GC Option exercise · Employee stock option (right to buy) 10b5-1 −20,000 20,000
2026-04-13 Cline Christopher R. CHIEF FINANCIAL OFFICER Grant or award 10b5-1 +14,000 125,226
2026-04-13 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale 10b5-1 −65 $28.85 $2K 125,161
2026-04-13 Inrig Jula CHIEF MEDICAL OFFICER Grant or award 10b5-1 +14,000 119,706
2026-04-13 Heerma Peter CHIEF COMMERCIAL OFFICER Grant or award +14,000 145,823
2026-04-13 Dube Eric M CHIEF EXECUTIVE OFFICER Grant or award 10b5-1 +64,000 496,886
2026-04-13 ROTE WILLIAM E. Chief Research Officer Grant or award 10b5-1 +14,000 123,087
2026-04-13 REED ELIZABETH E Chief Legal Officer and GC Grant or award 10b5-1 +14,000 119,211

Page 11 of 51 · 1,020 trades